Keranova raises €4 million in series A funding for prototype in automated surgery
Click Here to Manage Email Alerts
Keranova reported a series A funding investment of €4 million to finance development of prototype ophthalmic surgical equipment, according to a press release.
The technological innovation “allows for a substantial reduction in manual intervention in favor of automation and precision,” which reduces operator-dependent risk, according to the release.
The round was led by Mérieux Développement and CEA Investissement, with additional support of €1 million coming from French public investment bank Bpifrance, the release said.
“We are very pleased to welcome our new shareholder, two renowned investors who will help us make rapid inroads into the development of our first-generation product and the preparation of the clinical proof of concept,” Fabrice Romano, CEO and founder of Keranova, said.